Page 28 - தேசிய மனிதன் மரபணு ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Message : Required fields SAN FRANCISCO, April 8, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, has joined eMERGE Network, a nationwide effort organized and funded by the National Human Genome Research Institute (NHGRI) that connects genetic data and electronic medical record (EMR) systems to advance the use of genetics in healthcare. As a new clinical affiliate, Invitae will provide genetic testing for a study of up to 25,000 patients to evaluate the impact of population screening.  Our own research has shown that people can harbor a genetic change that could put them at increased risk for conditions like cancer and heart disease. The eMERGE study is part of the work conducted by the NHGRI to improve understanding of these rates in diverse populations, with an emphasis on underrepresented minorities, and identify best practices for population screening, said Robert Nussbaum, M.D., chief medical officer at Invitae. We re proud to be

Laura dangeloRobert nussbaumExchange commissionPrnewswire invitae corporationInvitae corporationNational human genome research institutePrivate securities litigation reform actAnnual reportலாரா டாங்கெலோராபர்ட் நுஸிசிபோும்பரிமாற்றம் தரகுதேசிய மனிதன் மரபணு ஆராய்ச்சி நிறுவனம்ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம்ஆண்டு அறிக்கை